Albireo Pharma, Inc. (NASDAQ: ALBO) dropped 23.5% to $19.00 after the company reported worse-than-expected Q2 EPS results and filed for a mixed shelf of up to $400 million.
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Mizuho has decided to maintain its Buy rating of RingCentral (NYSE:RNG) and lower its price target from $150.00 to $80.00.
Shares of RingCentral are trading up 6.76% over the last 24 hours, at $53.06 per share.
A move to $80.00 would account for a 50.77% increase from the current share price.